Author Archives: admin


Discovery of ‘Tendon Stem Cells’ Could Revolutionize How We Recover From Injuries – Good News Network

Debilitating tendon injuries may soon be a thing of the past now that researchers have discovered the existence of tendon stem cells for the first time.

The buildup of scar tissue makes recovery from torn rotator cuffs, jumpers knee, and other tendon injuries a painful, challenging process, often leading to secondary tendon ruptures.

New research led by Carnegies Chen-Ming Fan and published in Nature Cell Biology reveals the existence of tendon stem cells that could potentially be harnessed to improve tendon healing and even to avoid surgery.

Tendons are connective tissue that tether our muscles to our bones, Fan explained. They improve our stability and facilitate the transfer of force that allows us to move. But they are also particularly susceptible to injury and damage.

LOOK: Revolutionary New Arm Cast is Waterproof, Breathable, and Itch-Free

Unfortunately, once tendons are injured, they rarely fully recover, which can result in limited mobility and require long-term pain management or even surgery. The culprit is fibrous scars, which disrupt the tissue structure of the tendon.

Working with Carnegies Tyler Harvey and Sara Flamenco, Fan revealed all of the cell types present in the Patellar tendon, found below the kneecap, including previously undefined tendon stem cells.

Because tendon injuries rarely heal completely, it was thought that tendon stem cells might not exist, said lead author Harvey. Many searched for them to no avail, but our work defined them for the first time.

Stem cells are blank cells associated with nearly every type of tissue, which have not fully differentiated into a specific functionality. They can also self-renew, creating a pool from which newly differentiated cell types can form to support a specific tissues function. For example, muscle stem cells can differentiate into muscle cells. But until now, stem cells for the tendon were unknown.

CHECK OUT: Researchers Create AI System That Can Predict Epileptic Seizures One Hour Ahead of Time With 99.6% Accuracy

Surprisingly, the teams research showed that both fibrous scar tissue cells and tendon stem cells originate in the same spacethe protective cells that surround a tendon. Whats more, these tendon stem cells are part of a competitive system with precursors of fibrous scars, which explains why tendon healing is such a challenge.

The team demonstrated that both tendon stem cells and scar tissue precursor cells are stimulated into action by a protein called platelet-derived growth factor-A. When tendon stem cells are altered so that they dont respond to this growth factor, then only scar tissue and no new tendon cells form after an injury.

Tendon stem cells exist, but they must outcompete the scar tissue precursors in order to prevent the formation of difficult, fibrous scars, Fan explained. Finding a therapeutic way to block the scar-forming cells and enhance the tendon stem cells could be a game-changer when it comes to treating tendon injuries.

Reprinted from the Carnegie Institution for Science

Heal Your Friends Of Negativity By Sharing The Exciting News To Social Media

Read more:
Discovery of 'Tendon Stem Cells' Could Revolutionize How We Recover From Injuries - Good News Network

From Tiger Woods to Brooks Koepka, the 9 things we learned this fall on PGA Tour – Golf Channel

There was a time, not too long ago, when the fall portion of the PGA Tour schedule unfolded in a vacuum.

Few viewers. Limited interest. Little buzz.

Certain factors changed that dynamic. These days theres a clear sense of FOMO, the 11-tournament slate now representing nearly a quarter of the overall Tour calendar, and the addition of the big-money, no-cut events in Asia now offering a soft landing spot for the games elite to bank some free FedExCup points for the holidays.

The stars more frequent appearances are to our benefit, of course, and this was the best autumn the Tour has ever enjoyed.

From a record-tying win to a burgeoning rivalry to an all-time comeback, here are nine things we learned during the fall:

Itd be wrong to describe Justin Thomas' 2019 as a what-could-have-been season, considering he won once, earned more than $5 million and finished fifth in the FedExCup, but an early-season wrist injury derailed his momentum and cost him a chance to build on his majorrsum. Now 26, Thomas lone major remains the 2017 PGA, and he was a non-factor (or a no-show altogether) in the last three majors of the year. By late July hed rediscovered his world-beater form, and he blew away the field at the BMW Championship and then took it deep again at the CJ Cup.

Even in a down year he ranked fourth in strokes gained: overall. All signs point to a monster year in 2020.

That Kevin Na was able to outduel sixth-ranked Patrick Cantlay in Las Vegas was surprising enough. Then he walked off the 18thgreen and opened a vein.

Speaking in Korean for more than a minute, blinking back tears, Na attempted to address the false rumors to his fans back home. It was a puzzling rant for American viewers, but we soon learned the hidden meaning: Na was fed up with the lingering fallout from his broken engagement with a native Korean woman. Salacious details of the couples sex life had been tabloid fodder for years, and every time Na won (this was his fourth) the old stories were brought up again.

Na had stayed silent for five years, and his emotional public statement overshadowed what was a hard-fought victory.

With this compelling backdrop hes even more interesting than we already thought.

Less than one week after sending an emotional message back home to South Korea, Kevin Na is breaking the silence hes kept through years ofpersonal anguish.

Any discussion of the games young guns typically leaves out one of the youngest: Joaquin Niemann, who only turned 21 earlier this month. The Chilean didnt go to college, and so he didnt receive the same sort of splashy introduction as Matthew Wolff (20), Collin Morikawa (22) and Viktor Hovland (22).

Though he earned his Tour card without going through Q-School, Niemann fully announced his arrival with a resounding win in the season-opening Greenbrier. Hell soon star on another big stage, as a captains pick for the upcoming Presidents Cup.

The No. 1 player in the world is on the DL. This fall Brooks Koepka revealed that his knee had bothered him for months and required stem-cell treatment after the Tour Championship. Upon his return he said that he was happy to finally play pain-free, then he slipped on wet concrete in Korea and reinjured it.

Details on Koepkas injury have been sparse, but its troublesome enough that he withdrew from the Presidents Cup. His return date to the PGA Tour is unclear, but it doesnt figure to be a long-term issue hes signed up for another trip to Saudi Arabia in the middle of January.

With the extra time to heal, Koepka should come back firing in 2020.

Its possible that the build-up will be more interesting than the actual competition, which over the past two decades has been laughably one-sided. There was the will-he-or-wont-he? drama surrounding Tiger Woods playing-captain decision. There was Woods granting former pariah Patrick Reed a one-year reprieve. And then there was the uncertainty regarding the health of the No. 1 player in the world, with Koepka bowing out and Woods tapping a rusty Rickie Fowler with his extra captains pick.

Worldwide travel, a unique venue and the risk of embarrassment should keep this Presidents Cup close. But if its another American rout, at least the run-up to Royal Melbourne has been highly entertaining.

While some questioned Tiger Woods' decision to add Rickie Fowler to the U.S. Presidents Cup team, those who know Woods best aren't surprised.

Instead of withdrawing from the Safeway Open to spend more time with his ailing grandfather, Cameron Champ instead decided to honor him by playing and then winning.

Mack Champ had endured racial discrimination while growing up in Texas, but he was the man responsible for molding the game of one of the Tours uber-talented prospects.

Champ won in the fall of 2018 but tweaked his back and failed to live up to lofty expectations. Macks stomach-cancer diagnosis hit the family hard, and all Cameron needed to get back on track was a little inspiration.

In the teary aftermath of his victory in Napa, he said, This will be the greatest moment in my golf career.

The greatest, maybe not, but itll certainly be the most meaningful. Mack Champ died less than a month later.

Cameron Champ won the Safeway Open on Sunday, and he then celebrated through tears with his dad and grandpa (via phone).

It was a typical Brooks Koepka answer: Honest, blunt, with a dose of dismissiveness. When asked about the storyline that Rory McIlroy is threatening his throne, setting the stage for an epic duel in 2020, Koepka scoffed: Ive been out here for, what, five years? Rory hasnt won a major since Ive been on the PGA Tour. So I dont view it as a rivalry.

What Koepka said, of course, is true. And McIlroy didnt disagree, even if he said he didnt need to be reminded of his major shortcomings. Though McIlroy didnt fire back publicly, its reasonable to think that Brooks barb got under his skin. How could it not?

Letting his clubs do the talking, McIlroy finished the year strong: a third at the Zozo, a win at the WGC in China and then a fourth-place showing in Dubai, narrowing the gap at the top of the world rankings.

Koepka might not view this as the beginning of a rivalry with McIlroy, but his icy dismissal likely just created one.

World No. 1 Brooks Koepka downplayed the notion that there is any sort of rivalry between him and reigning FedExCup champ Rory McIlroy.

A year agoone-time Tour winner Brendon Toddconsidered opening a pizza franchise thats how dire things had gotten. The full-swing yips had torpedoed his confidence and left him without a permanent place to play, but his work with swing coach Bradley Hughes and mental coach Ward Jarvis kept him invested in the process.

Results were steady but unspectacular, at least until this fall, when he ripped off a win in Bermuda, backed it up in Mexico and then was 18 holes from notching three wins in four weeks.

Everyone loves a comeback story, but Todds is one of the most improbable in recent memory. He ended last year at No. 2,006 in the world. He now sits at 72nd.

Tiger Woods resounding Masters victory had us making bold predictions for the future 83! 19! and then he looked hobbled the rest of the season. It wasnt until this fall that we learned why hed fallen off: He underwent arthroscopic knee surgery to fix an issue that apparently had bothered him for a year.

When he showed up in Japan for the inaugural Zozo Championship, the conventional wisdom held that Woods would be rusty but needed a good performance to warrant a pick for the Presidents Cup. Then he looked nearly flawless in beating an elite, limited field to win for the 82ndtime on Tour, matching Sam Sneads all-time record.

Woods swing looks as pure as ever, but how hell play in 2020 is anyones guess. How will his soon-to-be 44-year-old body hold up to the stress of another full season? Will he add a few events to try and qualify for his last Olympics? Can he move even closer to Jack?

As always with Woods, itll be fascinating to watch.

See the original post here:
From Tiger Woods to Brooks Koepka, the 9 things we learned this fall on PGA Tour - Golf Channel

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Future Growth, Industry Verticals, and Research Forecast upto 2026 – The Denton Chronicle

The global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is fueled by various factors, according to a detailed assessment explained in the report. This study shows how important in-depth analysis should be, and how it greatly affects the quality of information provided to the readers. The market for Platelet Rich Plasma and Stem Cell Alopecia Treatment Market extensively covers various highlights in the report that includes competitive vista, growth propelling factors, regional outreach, targeted consumers, major obstacles, and others.

Get Free Sample PDF for Professional Insights:https://www.researchmoz.us/enquiry.php?type=S&repid=2227069

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Overview

This report analyzes the current and future scenario of the global platelet rich plasma & stem cell alopecia treatment market for the period 2018 to 2026. Rise in awareness about platelet rich plasma therapies and stem cell therapies, increase in funding for alopecia treatment research and stem cell research, and increase in the incidence of autoimmune hair loss disorders are likely to be major drivers of the global platelet rich plasma & stem cell alopecia treatment market during the forecast period.

The global platelet rich plasma & stem cell alopecia treatment market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on treatment, indication, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides presence of key players working in the development of stem cell and platelet rich pharmaceutical products, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet rich plasma & stem cell alopecia treatment market.

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Key Segments

Based on treatment, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into platelet rich plasma therapy and stem cell therapy. The stem cell therapy segment has been further classified into bone marrow treatment and adipose treatment. In terms of indication, the global platelet rich plasma & stem cell alopecia treatment market has been classified into androgenic alopecia, congenital alopecia, cicatricial or scarring alopecia and others. Based on end-user, the global platelet rich plasma & stem cell alopecia treatment market has been divided into hospitals, dermatology clinics, and others. The market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Regional Outlook

In terms of region, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Get Assistance on this report at:https://www.researchmoz.us/enquiry.php?type=E&repid=2227069

( *Fill the form and our sales representative will get back to you for assistance )

Companies Mentioned in the Report

The report also profiles major players operating in the global platelet rich plasma & stem cell alopecia treatment market based on various attributes, such as company overview, financial overview, pipeline portfolio, product portfolio, business strategies, and recent developments. The players covered in the report include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy.

The global platelet rich plasma & stem cell alopecia treatment market has been segmented as below:

Market Segment by Regions, regional analysis covers

Scope of the Market: This report focuses on the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Research objectives: To study and estimate the market size of Platelet Rich Plasma and Stem Cell Alopecia Treatment Market, in terms of value. To find growth and challenges for the global market. To study worthwhile expansions such as expansions, new services launches in Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market. To conduct the pricing analysis for the global market. To classify and assess the side view of important companies of Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Report gives answers to Following Vital Questions:1. What are the risks associated with the sourcing of raw material, or holding the line on costs of services?2. Who are the emerging competitors in the Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market?3. Expected percentage of the Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Growth over the upcoming period?4. Why does Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market have high growth potential?5. How does this report match with Investment Policy Statement?

For More Information Kindly Contact:

ResearchMozMr. Nachiket Ghumare,90 State Street,Albany NY,United States 12207Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected] Media Release: https://www.researchmoz.us/pressrelease

Follow us on Blogger @ https://buzzpocket.blogspot.com/

Read more from the original source:
Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Future Growth, Industry Verticals, and Research Forecast upto 2026 - The Denton Chronicle

Stem Cell Therapy Market Gain Impetus due to the Growing Demand over 2025 – Guru Online News

Stem cells are most vital cells found in both humans and non-human animals. Stem cells are also known as centerpiece of regenerative medicine. Regenerative medicines have capability to grow new cells and replace damaged and dead cells. Stem cell is the precursors of all cells in the human body. It has the ability to replicate itself and repair and replace other damaged tissues in the human body. In addition, stem cell based therapies are used in the treatment of several chronic diseases such as cancer and blood disorders.

The globalstem cell therapy marketis categorized based on various modes of treatment and by therapeutic applications. The treatment segment is further sub-segmented into autologous stem cell therapy and allogeneic stem cell therapy. The application segment includes metabolic diseases, eye diseases, immune system diseases, musculoskeletal disorders, central nervous system disorders, cardiovascular diseases and wounds and injuries.

Get Enquiry More About This Report:http://www.marketgrowthanalysis.com/reports/sample/217

Stem Cell Therapy Market, By Treatments:

Allogeneic Stem Cell TherapyAutologous Stem Cell Therapy

Stem Cell Therapy Market, By End Users:

HospitalsAmbulatory Surgical Centers

Stem Cell Therapy Market, By Application:

OncologyCentral Nervous System DiseasesEye DiseasesMusculoskeletal DiseasesWound & InjuriesMetabolic DisordersCardiovascular DisordersImmune System Disorders

Stem Cell Therapy Market, By Geography:

North AmericaEuropeAsia PacificMiddle East & AfricaLatin America

Get Request For Discount:http://www.marketgrowthanalysis.com/reports/enquiry/217

In terms of geographic, North America dominates the global stem cell therapy market due to increased research activities on stem cells. The U.S. represents the largest market for stem cell therapy followed by Canada in North America. However, Asia is expected to show high growth rates in the next five years in global stem cell therapy market due to increasing population. In addition, increasing government support by providing funds is also supporting in growth of the stem cell therapy market in Asia. China and India are expected to be the fastest growing stem cell therapy markets in Asia.

Key Players in the Stem Cell Therapy Market are:

Chiesi Farmaceutici S.P.A Are:Gamida CellReNeuron Group, plcOsiris Therapeutics, Inc.Stem Cells, Inc.Vericel Corporation.Mesoblast, Ltd.

Full View of Report Analysis:http://www.marketgrowthanalysis.com/stem-cell-therapy-market

Continue reading here:
Stem Cell Therapy Market Gain Impetus due to the Growing Demand over 2025 - Guru Online News

Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 – Avon Lake Ledger

The market research report of the global "Musculoskeletal Disorder Stem Cell Therapy Market" is a fundamental study carried out by experts with a perspective of the global market. It gets to the details of competing for the structure of industries worldwide. Composed by using proficient standardized tools like S.W.O.T Analysis, the global Musculoskeletal Disorder Stem Cell Therapy market research report provides a thorough judgment of the global Musculoskeletal Disorder Stem Cell Therapy market.

The global Musculoskeletal Disorder Stem Cell Therapy market research report provides a complete estimation of CAGR of the concerned period in percentages which will guide the users to take choice-based decisions over the predicted chart. The major players [Osiris Therapeutics, NuVasive, Takeda (TiGenix), Medi-post] who are leading the Musculoskeletal Disorder Stem Cell Therapy market throughout the globe are also covered in the report.

Ask for sample link here: http://www.marketresearchstore.com/report/global-musculoskeletal-disorder-stem-cell-therapy-market-2019-497936#RequestSample

The experts have calculated the size of the global Musculoskeletal Disorder Stem Cell Therapy market on the basis of 2 major aspects: 1) Income (US Dollars) and 2) Production Volume. The subtle analysis of the key chunks of the Musculoskeletal Disorder Stem Cell Therapy market and their geographical diversification [Allogeneic, Autologous] all the world has also been carried out. Numerous properties of the global Musculoskeletal Disorder Stem Cell Therapy market like upcoming aspects, limitations, and growth factors related to every segment [Muscle disease, Skeletal disease] of the report have been put up thoroughly.

The global Musculoskeletal Disorder Stem Cell Therapy market research report covers up each and every characteristic of the global Musculoskeletal Disorder Stem Cell Therapy market right from the basic fundamental info of the market to that of various important criteria based on which the global Musculoskeletal Disorder Stem Cell Therapy market has been diversified.

The global Musculoskeletal Disorder Stem Cell Therapy market research report covers an in-depth analysis of current policies, rules, and regulations along with the chain of global Industries. Other than this, factors like production chain, key producers, goods, supply as well as demand for those goods along with the price structure as well as the revenue are also covered in the global Musculoskeletal Disorder Stem Cell Therapy market research report.

Inquire about the report here: http://www.marketresearchstore.com/report/global-musculoskeletal-disorder-stem-cell-therapy-market-2019-497936#InquiryForBuying

The various properties of supply and demand, chronological presentation, manufacturing capacity along with the detailed analysis of the global Musculoskeletal Disorder Stem Cell Therapy market are also calculated in the global Musculoskeletal Disorder Stem Cell Therapy market research report.

Set of Chapters:

1. Musculoskeletal Disorder Stem Cell Therapy Market outline

2. International Musculoskeletal Disorder Stem Cell Therapy market Followed by makers

3. world Musculoskeletal Disorder Stem Cell Therapy Market capability, Generation, Sales (Worth ) by Region (2019-2028)

4. world Musculoskeletal Disorder Stem Cell Therapy Market provide (Production), Presence, Export, printed by Region (2019-2028)

5. International Musculoskeletal Disorder Stem Cell Therapy market Production, Revenue (Worth ), value Trend by kind

6. International Musculoskeletal Disorder Stem Cell Therapy marketing research by Application

7. Musculoskeletal Disorder Stem Cell Therapy Market makers Profiles/Analysis

8. Musculoskeletal Disorder Stem Cell Therapy Market producing analysis

9. Industrial Chain, Best Sourcing Strategy and Down-stream consumers

10. Marketing-strategy Analysis, Distributors/Traders

11. Market result sides designation

12. World Wide Musculoskeletal Disorder Stem Cell Therapy Market Forecast (2019-2028)

13. Musculoskeletal Disorder Stem Cell Therapy research Findings and call

14. Appendix

Research Objective :

Our panel of trade contributors moreover as trade analysts across the worth chain have taken vast efforts in doing this group action and heavy-lifting add order to produce the key players with useful primary & secondary data concerning the world Musculoskeletal Disorder Stem Cell Therapy market. additionally, the report additionally contains inputs from our trade consultants that may facilitate the key players in saving their time from the interior analysis half. firms WHO get and use this report are going to be completely profited with the inferences delivered in it. Besides this, the report additionally provides an in-depth analysis of Musculoskeletal Disorder Stem Cell Therapy sales moreover because of the factors that influence the shoppers moreover as enterprises towards this method.

Thanks for reading this article; you'll be able to additionally get individual chapter wise section or region wise report versions like North America, Europe, Asia-Pacific, South America, geographic area and continent."

Sorry! The Author has not filled his profile.

Continued here:
Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2025 - Avon Lake Ledger

Stem Cell Therapy Market Size, by Therapeutic Application (Musculoskeletal Disorders, Wounds and Injuries), by Cell Source (Adipose Tissue-derived…

Stem Cell Therapy MarketGlobal Industry Report provides a detailed analysis of the market historical data, facts, regional sales, industry share, growth factors, top manufacturers overview and forecast to 2026. Stem Cell Therapy market research study presents brief information about definitions, products market features, competitive landscape, market segmentation, business opportunity and expert opinions.

Get Sample Copy athttps://www.orianresearch.com/request-sample/1348964

The report firstly introduced the Stem Cell Therapy basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analysed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

With tables and figures helping analyse worldwide Stem Cell Therapy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. .

No. of Pages: 121

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Inquire more or share questions if any before the purchase on this report @https://www.orianresearch.com/enquiry-before-buying/1348964

The information for each competitor includes:

Market Share In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Stem Cell Therapy Report by Material, and Geography Global Forecast to 2026 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

Order a copy of Report @https://www.orianresearch.com/checkout/1348964

Key Points Table of Contents

Chapter 1 Stem Cell Therapy Industry Overview

Chapter 2 Stem Cell Therapy Up and Down Stream Industry Analysis

Chapter 3 Asia Stem Cell Therapy Market Analysis

Chapter 4 2014-2019 Asia Stem Cell Therapy Productions Supply Sales Demand Market Status and Forecast

Chapter 5 Asia Stem Cell Therapy Key Manufacturers Analysis

Chapter 6 Asia Stem Cell Therapy Industry Development Trend

Chapter 7 North American Stem Cell Therapy Market Analysis

Chapter 8 2014-2019 North American Stem Cell Therapy Productions Supply Sales Demand Market Status and Forecast

Chapter 9 North American Stem Cell Therapy Key Manufacturers Analysis

Chapter 10 North American Stem Cell Therapy Industry Development Trend

Chapter 11 Europe Stem Cell Therapy Market Analysis

Chapter 12 2014-2019 Europe Stem Cell Therapy Productions Supply Sales Demand Market Status and Forecast

Chapter 13 Europe Stem Cell Therapy Key Manufacturers Analysis

Chapter 14 Europe Stem Cell Therapy Industry Development Trend

Chapter 15 Stem Cell Therapy Marketing Channels Development Proposals Analysis

Chapter 16 Development Environmental Analysis

Chapter 17 Stem Cell Therapy New Project Investment Feasibility Analysis

Chapter 18 2014-2019 Global Stem Cell Therapy Productions Supply Sales Demand Market Status and Forecast

Chapter 19 Global Stem Cell Therapy Industry Development Trend

Chapter 20 Global Stem Cell Therapy Industry Research Conclusions

About Us

Orian Research is one of the most comprehensive collections of market intelligence reports on The World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (415) 830-3727 | UK: +44 020 8144-71-27

Email:[emailprotected]

See the original post:
Stem Cell Therapy Market Size, by Therapeutic Application (Musculoskeletal Disorders, Wounds and Injuries), by Cell Source (Adipose Tissue-derived...

Translink in Armagh holding stem cell registration event in memory of Gavin McNaney – Armagh i

Gavin McNaney, who passed away two years ago.

Translink are hosting a blood stem cell registration event and coffee morning this Saturday as part of the Somebodys Stranger campaign, in memory of Armagh man Gavin McNaney, who passed away two years ago.

It will take place from 10am until 2pm and it is a painless process which could potentially save a life.

Former St Catherines College teacher Gavin was just 37 years of age when he passed on November 18, 2017.

He had been diagnosed with Acute Lymphoblastic Leukaemia whilst teaching in Dubai.

Gavin spent months in hospital undergoing treatment and had a bone marrow transplant in London.

But after contracting a common cold and an infection to his lungs, his life was sadly cut short and he passed away peacefully with mum and dad, Nuala and Pat, by his side.

Friend Karl McQuaid has been raising funds and awareness after the passing of his life-long friend, whom he had first met when they both attended St Patricks Grammar School in Armagh.

He has been running registration events as part of his Somebodys Stranger campaign for nine months in Gavins memory and is keen to advise people just how easy it is to register .

He who would like to thank Leanne Armstrong and her colleagues at Translink for inviting them to come along told Armagh I : Joining the stem cell register is quick, easy and pain-free.

Potential donors have a swab taken of the inside of their cheeks with the whole process taking just a few minutes. They will then be added to DKMSs worldwide database and could be contacted at any time should they be a genetic match for a blood cancer sufferer anywhere in the world.

Those lucky enough to be a match would then be asked to donate their stem cells in a pain-free procedure similar to giving blood. This could save the life of the cancer sufferer.

Donations are at your own discretion at the event with all proceeds going to Leukaemia & Lymphoma NI Northern Irelands only charity dedicated to fighting blood cancers.

Those willing to join the register should be in general good health and aged between 18 and 55.

All are urged to come along on Saturday morning, when the city will be full of revellers for the annual Georgian Day event. Please take time to come along to the bus station and help make a huge difference.

See more here:
Translink in Armagh holding stem cell registration event in memory of Gavin McNaney - Armagh i

Comprehensive Research on Joint Pain Injections Market Report Offers Consumption, Production, CAGR, Market Size, Profit Margin And Revenue By 2028 -…

The report titled as a globalJoint Pain Injections Market Research Report: has recently added by MarketResearch.biz to get a stronger and effective business outlook. It provides a comprehensive analysis of different attributes of industries such as size, threats, growth ratio, opportunities, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the business owners, readers, and industry experts. The industry profiles discussed in the Joint Pain Injections report further identifies market profit, segmentation, and rival landscape and offers forecast data on industry performance and trends for the period 2019 to 2028. The detailed report offers analyses about a particular market situation within a geographic region.

The Joint Pain Injections Market focuses on the regional markets of Europe, Asia-Pacific, North America, Middle East & Africa, and Latin America. Also, the major details such as product types manufactured, production values, gross margins, production capacities, global share, company contact information, manufacturing processes, cost structures, etc. are included. A number of analytical tools, such as Porters Five forces Analysis and SWOT Analysis, have been used to provide an accurate understanding of this market.

For Better Understanding Go With This Free Sample Report Enabled With Respective Tables and Figures:Download PDF

The scope of the Joint Pain Injections Market Report ranges from market eventualities to comparative ratings between the major players, prices, and income of the relevant market regions. It offers a holistic view of the strategic dynamics of the industry. Some of the top players involved in the market are profiled completely in a systematic manner.

Some of the key players are: Allergan Plc., Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring B.V., Bioventus LLC, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Seikagaku Corporation, Chugai Pharmaceutical Co Ltd

Quantitative information includes Joint Pain Injections Market estimates & forecast for an upcoming year, at the global level, split across the key segments covered under the scope of the study, and the major regions and countries. Sales revenue and year-on-year growth analysis, consumption estimates, price estimation, and trend analysis, etc. will be a part of quantitative information for the mentioned segments and regions/countries. Qualitative information will discuss the key factors driving the restraining the growth of the market.

Joint Pain Injections Market has been segmented as:

Segmentation by Injection type:

Corticosteroid InjectionsHyaluronic Acid InjectionsOthers (include, Platelet-rich plasma (PRP), Placental tissue matrix (PTM), etc.)Segmentation by joint type:

Knee & AnkleHip JointShoulder & ElbowFacet Joints of the SpineOthers (include, Ball and socket, etc.)Segmentation by end-user:

Hospital PharmaciesRetail PharmaciesOnline Pharmacies

Inquire/Speak To Expert for Further Detailed Information About Joint Pain Injections Report:https://marketresearch.biz/report/joint-pain-injections-market/#inquiry

Key questions answered in the report

What will be the size of the market in terms of value and volume in the next 10 years?

Which segment is currently lead the market?

In which region will the market have the highest growth rate?

Which players will take the lead in the market?

What are the key drivers and restraints of the markets growth?

Share Your Questions Here For More Details On this Report or Customizations As Per Your Need:https://marketresearch.biz/report/joint-pain-injections-market/#request-for-customization

Media Contact:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876

Website:https://marketresearch.biz

Email ID:[emailprotected]

See the original post here:
Comprehensive Research on Joint Pain Injections Market Report Offers Consumption, Production, CAGR, Market Size, Profit Margin And Revenue By 2028 -...

ENCORE: Why There Are So Few Black Men In Medicine; Family of Stem Cell Donor Connects With Recipient 20 Years Later; Forecasting Volcanic Eruptions -…

Last year, fewer than 4% of incoming medical students in Illinois were black men. Today: whats behind that number,and what should be done about it. Plus,decades ago, a cutting edge stem cell treatment from umbilical cord blood saved one Illinois woman's life. And earlier this year, she met her donor and his parents for the first time.And, wetalk to a University of Illinois geology professor about her work, on how to better forecast volcanic eruptions

Black Men In Medicine

Last year, fewer than 4% of incoming medical students here in Illinois were black men. That number can be surprising on the surface, but it could also have more serious health implications for all African-American men.

And the path to medicine comes with many obstacles. Some students dont get the support they need beforehand and even if they do, going to med school is incredibly expensive.

Stephanie Whiteside reported on this for Illinois Newsroom. And Dr. Don Arnold is Chief of Surgery at Herrin Hospital, just outside of Carbondale.

They both spoke with Brian Moline this past spring.

Family of Stem Cell Donor Connects With Recipient 20 Years Later

In 1994, DaniaDavey and her husband made an important decision. Although she didnt quite realize how important it was at the time, that decision would save a young womans life hundreds of miles away.

That woman is Holly Becker, who was 24 when she received a stage 4 cancer diagnosis. Hollys oncologist at Loyola Medicine in Maywood, Illinois decided to try a cutting edge treatment at the time in the 90s: a stem cell transplant from donated umbilical cord blood.

That cord blood came from Danias son Patrick. It was donated and frozen the day he was born in New York.

Holly is now cancer free. And she met the Daveys earlier this year in Illinois. Its thought to be one of the first times a stem cell donor from umbilical cord blood has met the recipient.

Dania Davey now lives in New York. Holly Becker is in the Chicago suburbs, along with her oncologist, Dr. Patrick Stiff from Loyola University Medical Center.

The three of them spoke with Brian Moline earlier this year.

Forecasting Volcanic Eruptions

When it comes to forecasting severe weather events like hurricanes, tornadoes or earthquakes, accuracy is key. Knowing what to expect and when to expect it can mean the difference between life and death.

Now, researchers at the University of Illinois are part of a new study looking at ways we can better forecast volcanic eruptions. Theyve been studying one which happened in Alaska back in 2008,which traditional forecasting models missed.

Researchers are now using new computer models to paint a more accurate picture about if and when we can expect volcanic eruptions.

Trish Gregg is a geology professor at the University of Illinois. She spoke with Brian Moline back in September.

See more here:
ENCORE: Why There Are So Few Black Men In Medicine; Family of Stem Cell Donor Connects With Recipient 20 Years Later; Forecasting Volcanic Eruptions -...

Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles – PR Web

It is an honor to help support the Arthritis Foundation and to work closely with the Orthohealing Center.

POWAY, Calif. (PRWEB) November 26, 2019

Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, recently sponsored an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California. The event, which took place on October 23, 2019, highlighted the ongoing efforts to promote research, educate the public, and provide support to people with arthritis.

Event attendees included medical doctors, physical therapists, chiropractors, and other medical professionals. Dr. Sampson presented current and evolving regenerative and stem cell therapies, including PSCs FDA approved clinical trial to treat osteoarthritis in the knee with a persons own stem cells. The Orthohealing Center is one of several approved clinical trial sites and is currently screening and enrolling patients in the clinical trial.

PSC CEO, Michael Dale, stated, It is an honor to help support the Arthritis Foundation and to work closely with the Orthohealing Center. The Foundation and the Orthohealing Center have worked together for many years advocating and spreading awareness for arthritis patients.

PSC provides stem cell therapy for clinical trial investigators and their patients, working within the FDA cell therapy regulations in order to assure consistent manufacturing, quality tested cells, as well as clinical trial and manufacturing oversite for safety and efficacy. PSC was founded by Robert Harman, DVM, MPVM and Michael Dale, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

About Personalized Stem Cells, Inc.Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patients own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Share article on social media or email:

Read this article:
Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles - PR Web